https://www.selleckchem.com/pr....oducts/gusacitinib.h
QoL was affected moderately to extremely in 70.7% of patients. Also, 26 patients (63.4%) were at risk for psychological disorders. Lower QoL was reported by patients age 45 years ( .05). Both QoL and general health had a negative relation with the disease activity index ( .05), but were not affected by sex, marital status, education level, treatment type, presence of mucous lesions, and disease duration. LPP significantly affects patients' QoL and general health. Dermatologists should address these issues in patients
Like
Comment
Share
